AzTrials
AzTrials

Delirium, PostoperativeNCT06302517

Bis Monitoring Effect on Delirium Occurrence and Nursing Quality Improvement Recovering From General Anesthesia

A study testing BIS-guided in people with Delirium, Postoperative, run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

①Effects of BIS Index (BIS) monitoring on delirium incidence in Post-anesthesia care unit (PACU) in patients undergoing general anesthesia ②Effects of BIS BIS Index (BIS) monitoring on the quality of nursing care in the Post-anesthesia care unit (PACU) Read more about this study

Who is it for?
Ages 20 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Delirium, Postoperative
What is being tested?
BIS-guided
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
134 participants
Where
1 siteChina
Study dates
1 Sep 2020to 29 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age ranging from 20 to 80 years
  • estimated operation time of 2 to 3 h
  • body mass index ≤30 kg/m2
  • normal preoperative heart, liver, lung, and renal function.

Who cannot join

  • Past cognitive impairment (dementia, cognitive impairment, mental illness or mental disorder)
  • Complex injuries: multiple fractures, chest and abdomen, pelvic and sacral trauma, head trauma, etc
  • Contraindications to intraspinal puncture (coagulation dysfunction, thrombocytopenia, intraspinal space occupation, puncture site infection, etc.)
  • Have a history of acute myocardial infarction or stroke within 3 months
  • Patients with severe liver dysfunction (Child-Pugh C) or renal failure
  • Contraindications to ketamine, such as malignant hypertension

Trial locations and contacts

1 site in 1 country.

China1 site
  • The Fourth Affiliated Hospital, School of Medicine, Zhejiang University

    Jinhua, Zhejiang, 322000

Other trials in China

About this study

Official title: Bispectral Index Monitoring Effect on Delirium Occurrence and Nursing Quality Improvement in Post-anesthesia Care Unit Patients Recovering From General Anesthesia

①Effects of BIS Index (BIS) monitoring on delirium incidence in Post-anesthesia care unit (PACU) in patients undergoing general anesthesia

②Effects of BIS BIS Index (BIS) monitoring on the quality of nursing care in the Post-anesthesia care unit (PACU)

Read the detailed description

The effect of intraoperative anesthesia depth monitoring on delirium occurrence and improvement of nursing quality in the post-anesthesia care unit (PACU) remains unclear. We aimed to explore the effect of intraoperative anesthesia bispectral index (BIS) monitoring on delirium occurrence and improvement of nursing quality in the PACU for patients recovering from general anesthesia.

This randomized controlled trial included 120 patients, aged 20-80 years and classified as grades I-III according to the American Society of Anesthesiologists. The BIS-guided group (group B) underwent intraoperative monitoring of BIS anesthesia depth (maintained within the anesthetic range [40-60]). The depth of anesthesia was not monitored in the non-BIS-guided group (group C). The patients' vital signs were recorded at the beginning of the operation (T0), upon entering the PACU (T1), 15 min after extubation (T2), and after leaving the PACU (T3). Delirium score, emergence period (extubation and PACU observation times), and adverse events in the PACU were monitored. The nursing activity score (NAS) was used to evaluate the quality of care.

Being tested
BIS-guided
Keywords
bispectral index; postoperative delirium
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BIS-guidedDevice

    underwent intraoperative monitoring of BIS anesthesia depth

Study groups in NCT06302517
Study groupRoleWhat they receive
non-BIS-guided group (group C)No interventionThe depth of anesthesia was not monitored in the non-BIS-guided group (group C).
BIS-guided group (group B)ExperimentalThe BIS-guided group (group B) underwent intraoperative monitoring of BIS anesthesia depth
Receives: Device: BIS-guided

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ricker sedation-agitation scale

    Delirium was assessed using the Ricker sedation-agitation scale (SAS; unable to awaken = 1, very calm = 2, calm = 3, quiet cooperation = 4, agitated = 5, very agitated = 6, and dangerously agitated = 7)

    Measured: ■evaluate immediately after recovery and tracheal intubation removal ■every five minutes after that ■take the highest value until the patient leave PACU

  2. The nursing activity score (NAS)

    The nursing activity score (NAS), consists of 23 nursing items in five aspects, including monitoring health care, supporting patients and their families, and managing nursing administration. Each item was assigned a score of 1.2-32.0 according to the percentage of time spent on the task during a nurse's working day. The higher the score, the greater the workload. The NAS score of each patient ranged from 0-177, and the assessment was conducted at the beginning of resuscitation in the PACU by a trained investigator according to the nursing work items on the NAS scale.

    According to the nursing records of patients, the nursing workload of PACU was evaluated and by the contents of NAS scale.

    Measured: ■at the begin of the patient enter PACU ■end with the transfer out of the PACU ■any nursing activitise will be scored

  3. vital signs (Mean arterial pressure, heart rate, pulse oxygen saturation )

    collected from monitors (Mean arterial pressure, heart rate, pulse oxygen saturation)

    Measured: ■ at the beginning of surgery (T0), ■at the time of extubation (T1), ■10 minutes after extubation (T2), ■at the time of leaving the PACU (T3: when patients were transferred from the PACU to the ward).

  4. Comparison of complications during the PACU period

    including postoperative delirium, nausea, vomiting, respiratory complications (e.g., SPO2 < 90%, arterial oxygen partial pressure < 60 mmHg, or interventions requiring mask compression, oxygen supply, manual mandibular ventilation, and intubation), cardiovascular-related complications (e.g., blood pressure exceeding 20% of preoperative value, HR < 120 beats /min or < 50 beats /min, emerging arrhythmia, and ischemia), severe pain, chills/hypothermia (skin temperature < 35 °C), and unplanned transfer to ICU.

    Measured: The patients were transferred to PACU after surgery, the period during the PACU

  5. The comprehensive satisfaction score

    The comprehensive satisfaction score for anesthesia and nursing. The satisfaction score was categorized as excellent or generally poor based on criteria such as postoperative pain, influence on daily activities, and emotional stability. Excellent satisfaction indicated no or mild pain after surgery, no interference with daily activities, and emotional stability. General satisfaction indicated moderate pain that was tolerable, daily activities that were not affected or slightly reduced, and emotional stability. Poor satisfaction indicated moderate pain, significantly limited patient activities, low mood, or irritability.

    Measured: The patients were followed up 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2024
  2. Study start1 Sep 2020
  3. Primary completion31 May 2022
  4. Study completion29 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
134 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06302517
Sponsor's protocol ID
K2020097
Status last verified
Mar 2024
First submitted
20 Feb 2024
Last updated
8 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing BIS-guided in people with Delirium, Postoperative, run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ricker sedation-agitation scale (time frame: ■evaluate immediately after recovery and tracheal intubation removal ■every five minutes after that ■take the highest value until the patient leave PACU). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in